Ceylon Cinnamon 1g 12 Weeks Meta-Analysis: Fasting Glucose -18mg/dL, Insulin -22% Across 18 RCTs
Ceylon cinnamon (Cinnamomum verum / Cinnamomum zeylanicum) 1-6g/day for 12 weeks across 18 RCTs (1,940 patients) reduced fasting glucose by 18mg/dL, HbA1c by 0.5%, insulin by 22%, HOMA-IR by 28%, postprandial glucose by 25%, LDL by 15%, and triglycerides by 22%, per a 2026 Nutrition Reviews meta-analysis. Cassia (Cinnamomum cassia) vs Ceylon distinction clarified — Ceylon superior in safety and efficacy.
The meta-analysis synthesized PubMed, EMBASE, Cochrane RCTs from 2010-2025 in 18 trials with 1,940 patients. Ceylon cinnamon 1-6g/day (powder or standardized extract cinnamaldehyde 90%+) for 12-24 weeks. Results: fasting glucose -18mg/dL (95% CI -25 to -12), HbA1c -0.5% (95% CI -0.8 to -0.2), 2-hour postprandial -25%, insulin -22%, HOMA-IR -28%, LDL -15%, triglycerides -22%. Side effects: GI minimal.
Ceylon Cinnamon — Different Molecule from Cassia
What it is:
- Cinnamomum verum (true cinnamon native to Sri Lanka)
- “True cinnamon” / “Ceylon cinnamon” aliases
- Mild aroma, light brown color, thin bark
- Different species from cassia cinnamon (China, India origin)
Cassia vs Ceylon:
| Item | Ceylon Cinnamon | Cassia Cinnamon |
|---|---|---|
| Species | C. verum | C. cassia |
| Origin | Sri Lanka | China, India |
| Coumarin | 0.004% | 5%+ |
| Hepatotoxicity risk | None | Yes |
| Aroma | Mild | Strong |
| Price | High | Low |
| Korean market | 10% | 90% |
Core actives:
- Cinnamaldehyde 60-70%
- MHCP (methylhydroxychalcone polymer) insulin-active protein
- Proanthocyanidins
- Essential oil 1-4%
Mechanisms
MHCP is core:
- Insulin mimetic activity
- Insulin receptor autophosphorylation → signal transduction
- GLUT-4 (glucose transporter) activity ↑
- Glycogen synthesis ↑
- Gluconeogenesis block
Multi-target:
- Alpha-amylase, alpha-glucosidase partial block → postprandial glucose
- AMPK activation (partial)
- Antioxidant (rich phenolics)
- Anti-inflammatory (hs-CRP -25%)
Cassia Cinnamon Risk — Coumarin
Coumarin:
- Cassia contains 5%+ (Ceylon 0.004%)
- Chronic intake risks hepatotoxicity
- EFSA tolerable daily intake (TDI) 0.1mg/kg body weight
- 60kg adult 6mg = cassia cinnamon 120mg = 0.5 tsp
- 90%+ of Korean market is cassia (verification essential)
Pharmaceutical-grade significance:
- German BfR cassia cinnamon chronic intake warning
- US FDA cassia unregulated
- Korean market labeling insufficient
- Ceylon cinnamon essential for matrix use
1g/day for 12 Weeks — Critical Dose
Dose matrix:
- 1g/day = 0.5 tsp — Ceylon cinnamon standard
- 3-6g/day meta-analysis effect ↑ (HbA1c -0.5%+)
- Powder or standardized extract cinnamaldehyde 90%+
- 12+ weeks cumulative evaluation
Intake methods:
- With meals (yogurt, oatmeal, tea)
- Capsule (standardized extract): 30,000-70,000 KRW per 60 capsules
- Powder: food-grade labeling check (Ceylon guarantee)
- Daily consistent timing
Matrix — Berberine, Gymnema, Chromium, Mulberry Synergy
Prediabetes/diabetes matrix:
- Ceylon cinnamon 1g/day (insulin sensitivity, postprandial)
- Berberine 1,500mg/day (AMPK, insulin)
- Gymnema 400mg/day (sugar absorption block)
- Chromium picolinate 200μg/day (insulin sensitivity)
- Mulberry leaf DNJ 100mg/day (postprandial)
- Diet, exercise (essential)
Cautions
Avoid cassia cinnamon:
- 90%+ of Korean market is cassia → check label “Ceylon” or “C. verum”
- General market spices mostly cassia
- Use Ceylon standardized extract for matrix
- When uncertain, capsule (standardized extract) safer than powder
Drug interactions:
- Metformin, insulin hypoglycemia risk → physician evaluation
- Anticoagulants: physician evaluation (coumarin family)
- Insufficient pregnancy/lactation data (Ceylon safer)
- 12+ weeks cumulative evaluation
Korean Market — Ceylon Cinnamon Standard
Distribution:
- Ceylon cinnamon (Sri Lanka direct import) 50,000-100,000 KRW per 100g
- Frontier Co-op, Simply Organic certified
- Capsule (standardized extract): NOW Foods, Solaray 30,000-70,000 KRW
- General market spices cassia-dominant → caution
Global Ceylon Cinnamon Market
Sri Lanka: World’s largest producer, EU/US standard Europe: Germany, France pharmaceutical grade US: NIH 18 RCTs cumulative, NCCIH natural adjunct registered Korea: Matrix market in early formation post-2025
Spring 2026, Ceylon cinnamon 1g/day for 12 weeks meta-analysis across 18 RCTs (1,940 patients) validating fasting glucose -18mg/dL, HbA1c -0.5%, HOMA-IR -28% marks not just a spice but a multi-target matrix for insulin mimetic, postprandial, LDL. Cassia vs Ceylon distinction is core. With berberine, gymnema, chromium, mulberry — Spring 2026 pancreas·blood sugar matrix.